AMRS:NSD-Amyris, Inc (USD)

COMMON STOCK | Specialty Chemicals | NSD

Last Closing Price

USD 10.39

Change

0.00 (0.00)%

Market Cap

USD 2.61B

Volume

4.02M

Average Target Price

USD 7.00 (-32.63%)
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict

About

Amyris, Inc., a biotechnology company, develops technology that creates microbial strains to produce artemisinic acid, a precursor of artemisinin, an anti-malarial drug. The company's technology platform enables to engineer microbes and use them as catalysts to metabolize renewable, plant-sourced sugars into large volume, high-value ingredients. It applies technology platform to engineer, manufacture, and sell products for the clean health and beauty, and flavor and fragrance markets. The company operates under the Amyris, Biofene, Biossance, Pipette, Purecane, and No Compromise trademarks. Amyris, Inc. has a collaboration agreement with the Infectious Disease Research Institute to advance a novel ribonucleic acid vaccine platform, including accelerating the development of a COVID-19 vaccine. The company was formerly known as Amyris Biotechnologies, Inc. and changed its name to Amyris, Inc. in June 2010. Amyris, Inc. was founded in 2003 and is headquartered in Emeryville, California. Address: 5885 Hollis Street, EmeryVille, CA, United States, 94608

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2021-01-24 )

Largest Industry Peers for Specialty Chemicals

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
WDFC WD-40 Company

N/A

USD3.95B 55.14 40.44
BCPC Balchem Corporation

N/A

USD3.81B 46.21 25.18
IOSP Innospec Inc

N/A

USD2.37B 63.94 22.77
GEVO Gevo, Inc

N/A

USD1.62B 0.30 N/A
GPRE Green Plains Inc

N/A

USD0.69B 40.40 N/A
HWKN Hawkins, Inc

N/A

USD0.58B 17.48 9.55
LOOP Loop Industries, Inc

N/A

USD0.39B N/A N/A
NTIC Northern Technologies Internat..

N/A

USD0.13B 59.49 39.49
HDSN Hudson Technologies, Inc

N/A

USD0.05B 31.20 12.05
GURE Gulf Resources, Inc

N/A

USD0.04B 35.50 9.44

ETFs Containing AMRS

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Specialty Chemicals)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 68.12% 92% A- 96% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 68.12% 92% A- 96% A
Trailing 12 Months  
Capital Gain 265.85% 77% C+ 93% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 265.85% 77% C+ 93% A
Trailing 5 Years  
Capital Gain -54.43% 18% F 12% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -54.43% 18% F 10% F
Average Annual (5 Year Horizon)  
Capital Gain -8.85% 15% F 18% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -8.85% 15% F 17% F
Risk Return Profile  
Volatility (Standard Deviation) 66.30% 38% F 18% F
Risk Adjusted Return -13.35% 31% F 27% F
Market Capitalization 2.61B 85% B 77% C+
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Specialty Chemicals)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio N/A N/A N/A N/A N/A
Price/Book Ratio N/A N/A N/A N/A N/A
Price / Cash Flow Ratio -16.62 69% D+ 80% B-
EV/EBITDA N/A N/A N/A N/A N/A
Management Effectiveness  
Return on Equity N/A N/A N/A N/A N/A
Return on Invested Capital 143.91% 100% A+ 99% A+
Return on Assets -56.92% 15% F 4% F
Debt to Equity Ratio -18.94% 100% A+ 94% A
Technical Ratios  
Short Ratio 4.94 31% F 26% F
Short Percent 18.05% 17% F 11% F
Beta 1.05 54% F 57% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector